在 COVID-19 中使用皮质类固醇：一概而论并不合适。
Corticosteroids in COVID-19: one size does not fit all.
机构信息
Respiratory Medicine Dept, University Hospital of Ioannina, Ioannina, Greece.
Respiratory Medicine Dept, University Hospital of Ioannina, Ioannina, Greece
出版信息
Eur Respir J. 2021 Apr 15;57(4). doi: 10.1183/13993003.00224-2021. Print 2021 Apr.
Abstract
摘要
[链接]
相似文献
1
Corticosteroids in COVID-19: one size does not fit all.在 COVID-19 中使用皮质类固醇：一概而论并不合适。
Eur Respir J. 2021 Apr 15;57(4). doi: 10.1183/13993003.00224-2021. Print 2021 Apr.
2
Corticosteroids May Be Indicated in Children with Severe COVID-19 Disease.对于患有重症新冠疾病的儿童，可能需要使用皮质类固醇。
Pediatr Ann. 2021 Jul;50(7):e270-e271. doi: 10.3928/19382359-20210701-01. Epub 2021 Jul 1.
3
Reply: Corticosteroids May Be Indicated in Children with Severe COVID-19 Disease.回复：对于患有重症新冠疾病的儿童，可能需要使用皮质类固醇。
Pediatr Ann. 2021 Jul;50(7):e271. doi: 10.3928/19382359-20210520-01. Epub 2021 Jul 1.
4
The Uncertain Role of Corticosteroids in the Treatment of COVID-19-Reply.皮质类固醇在新型冠状病毒肺炎治疗中的不确定作用——回复
JAMA Intern Med. 2021 Jan 1;181(1):140-141. doi: 10.1001/jamainternmed.2020.2435.
5
Therapeutic Application of Corticosteroids in COVID-19: A Focus on Optimum Dose and Duration of Therapy.皮质类固醇在COVID-19中的治疗应用：聚焦最佳治疗剂量和疗程
J Clin Pharmacol. 2021 Sep;61(9):1145-1148. doi: 10.1002/jcph.1929. Epub 2021 Jul 10.
6
Early, low-dose, short-term methylprednisolone decreased the mortality in critical COVID-19 patients: A multicenter retrospective cohort study.早期、低剂量、短期使用甲泼尼龙可降低重症COVID-19患者的死亡率：一项多中心回顾性队列研究。
J Infect. 2021 Apr;82(4):84-123. doi: 10.1016/j.jinf.2020.11.001. Epub 2020 Nov 8.
7
Methylprednisolone therapy induces differential metabolic trajectories in severe COVID-19 patients.甲泼尼龙治疗诱导重症 COVID-19 患者产生不同的代谢轨迹。
mSystems. 2023 Dec 21;8(6):e0072623. doi: 10.1128/msystems.00726-23. Epub 2023 Oct 24.
8
Corticosteroid Protection Against COVID-19: Begin with the Nose.皮质类固醇对新冠病毒的防护：从鼻腔开始。
J Allergy Clin Immunol Pract. 2021 Nov;9(11):3941-3943. doi: 10.1016/j.jaip.2021.08.025. Epub 2021 Sep 17.
9
Corticosteroids in patients with COVID-19: use and misuse.COVID-19 患者的皮质类固醇：使用与滥用。
Minerva Anestesiol. 2021 Sep;87(9):1042-1048. doi: 10.23736/S0375-9393.21.15625-1. Epub 2021 Jun 8.
10
Are intravenous corticosteroid pulses superior to low dose corticosteroids in patients with severe COVID-19?静脉注射皮质类固醇冲击是否优于小剂量皮质类固醇治疗重症 COVID-19 患者？
Eur Respir J. 2022 Oct 20;60(4). doi: 10.1183/13993003.01220-2022. Print 2022 Oct.
引用本文的文献
1
A Retrospective Data Audit of Outcome of Moderate and Severe Covid-19 Patients Who Had Received MP and Dex: A Single Center Study.对接受甲泼尼龙（MP）和地塞米松治疗的中重度新冠肺炎患者结局的回顾性数据审计：一项单中心研究
Infect Drug Resist. 2024 Dec 9;17:5491-5505. doi: 10.2147/IDR.S418788. eCollection 2024.
2
Efficacy and safety of glucocorticoids in the treatment of COVID-19: a systematic review and meta-analysis of RCTs.糖皮质激素治疗 COVID-19 的疗效和安全性：RCT 的系统评价和荟萃分析。
Clin Exp Med. 2024 Jul 13;24(1):157. doi: 10.1007/s10238-024-01405-0.
3
The Relationship between COVID-19 and Hypothalamic-Pituitary-Adrenal Axis: A Large Spectrum from Glucocorticoid Insufficiency to Excess-The CAPISCO International Expert Panel.新型冠状病毒肺炎与下丘脑-垂体-肾上腺轴的关系：从糖皮质激素不足到过度的大谱- CAPISCO 国际专家小组。
Int J Mol Sci. 2022 Jun 30;23(13):7326. doi: 10.3390/ijms23137326.
4
Severity-Adjusted Dexamethasone Dosing and Tocilizumab Combination for Severe COVID-19.严重 COVID-19 的调整剂量地塞米松和托珠单抗联合治疗。
Yonsei Med J. 2022 May;63(5):430-439. doi: 10.3349/ymj.2022.63.5.430.
5
Personalized therapy: can it tame the COVID-19 monster?个体化治疗：能否驯服 COVID-19 这头怪兽？
Per Med. 2021 Sep;18(6):583-593. doi: 10.2217/pme-2021-0077. Epub 2021 Oct 15.
6
Tocilizumab administration for the treatment of hospitalized patients with COVID-19: A systematic review and meta-analysis.托珠单抗治疗 COVID-19 住院患者的疗效：系统评价和荟萃分析。
Respirology. 2021 Nov;26(11):1027-1040. doi: 10.1111/resp.14152. Epub 2021 Oct 3.
7
A Multidisciplinary Approach to Coronavirus Disease (COVID-19).冠状病毒病（COVID-19）的多学科处理方法。
Molecules. 2021 Jun 9;26(12):3526. doi: 10.3390/molecules26123526.
8
Dexamethasone in the Treatment of COVID-19: Primus Inter Pares?地塞米松在治疗新型冠状病毒肺炎中的作用：首屈一指？
J Pers Med. 2021 Jun 15;11(6):556. doi: 10.3390/jpm11060556.
9
Steroid use in elderly critically ill COVID-19 patients.老年危重症 COVID-19 患者使用类固醇。
Eur Respir J. 2021 Oct 7;58(4). doi: 10.1183/13993003.00979-2021. Print 2021 Oct.
Zotero 插件